• 1
    Cook RP: Distribution of sterols in organisms and in tissues. In Cholesterol. Chemistry, Biochemistry, and Pathology (Ed. Cook RP), p. 145180. New York: Academic Press Inc., 1958
  • 2
    Vanhanen H, Kesaniemi YA, Miettinen TA: Pravastatin lowers serum cholesterol, cholesterol-precursor sterols, fecal steroids, and cholesterol absorption in man. Metabolism 1992; 41: 588595
  • 3
    Sudhop T, Lütjohann D, Kodal A, Igel M, Tribble DL, Shah S, Perevozskaya I, von Bergmann K: Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation 2002; 106: 19431948
  • 4
    Turley SD, Dietschy JM: The metabolism and excretion of cholesterol by the liver. In The Liver: Biology and Pathobiology (Eds. Arias IM, Jakoby WB, Popper H, Schachter D, Shafritz DA), p. 617641. New York: Raven Press, 1988
  • 5
    Dietschy JM, Turley SD, Spady DK: Role of liver in the maintenance of cholesterol and low-density lipoprotein homeostasis in different animal species, including humans. J Lipid Res 1993; 34: 16371659
  • 6
    Grundy SM: Alternative approaches to cholesterol-lowering therapy. Am J Cardiol 2002; 90: 11351138
  • 7
    Tso P: Intestinal lipid absorption. In Physiology of the Gastrointestinal Tract (Ed. Johnson LR), p. 18671907. New York: Raven Press, 1994
  • 8
    Phillips C, Murugasu G, Owens D, Collins P, Johnson A, Tomkin GH: Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in Type 2 diabetes. Atherosclerosis 2000; 148: 283291
  • 9
    Grundy SM: Absorption and metabolism of dietary cholesterol. Ann Rev Nutr 1983; 3: 7196
  • 10
    Ginsberg HN: New perspectives on atherogenesis: Role of abnormal triglyceride-rich lipoprotein metabolism. Circulation 2002; 106: 21372142
  • 11
    Mamo JCL, Proctor SD, Smith D: Retention of chylomicron remnants by arterial tissue: Importance of an efficient clearance mechanism from plasma. Atherosclerosis 1998; 141: S63S69
  • 12
    Turley SD, Dietschy JM: Sterol absorption by the small intestine. Curr Opin Lipidol 2003; 14: 233240
  • 13
    Altmann SW, Davis HR Jr, Zhu L-J, Yao X, Hoos LM, Tetzloff G, Iyer SPN, Maguire M, Golovko A, Zeng M, Wang L, Murgolo N, Graziano MP: Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption. Science 2004; 303: 12011204
  • 14
    Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, Kwiterovich P, Shan B, Barnes R, Hobbs HH: Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000; 290: 17711775
  • 15
    Lee M-H, Lu K, Hazard S, Yu H, Shulenin S, Hidaka H, Kojima H, Allikmets R, Sakuma N, Pegoraro R, Srivastava AK, Salen G, Dean M, Patel SB: Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 2001; 27: 7983
  • 16
    Connor WE, Lin DS: The intestinal absorption of dietary cholesterol by hypercholesterolemic (type II) and normocholesterolemic humans. J Clin Invest 1974; 53: 10621070
  • 17
    Nestel PJ, Havenstein N, Homma Y, Scott TW, Cook LJ: Increased sterol excretion with polyunsaturated-fat high-cholesterol diets. Metabolism 1975; 24: 189198
  • 18
    Crouse JR, Grundy SM, Johnson JH: Effects of AOMA on cholesterol metabolism in man. Metabolism 1982; 31: 733739
  • 19
    McMurry MP, Connor WE, Lin DS, Cerqueira MT, Connor SL: The absorption of cholesterol and the sterol balance in the Tarahumara Indians of Mexico fed cholesterol-free and high cholesterol diets. Am J Clin Nutr 1985; 41: 12891298
  • 20
    Briones ER, Steiger DL, Palumbo PJ, O'Fallon WM, Langworthy AL, Zimmerman BR, Kottke BA: Sterol excretion and cholesterol absorption in diabetics and nondiabetics with and without hyperlipidemia. Am J Clin Nutr 1986; 44: 353361
  • 21
    Kesäniemi YA, Miettinen TA: Cholesterol absorption efficiency regulates plasma cholesterol level in the Finnish population. Eur J Clin Invest 1987; 17: 391395
  • 22
    McNamara DJ, Kolb R, Parker TS, Batwin H, Samuel P, Brown CD, Ahrens EH Jr: Heterogeneity of cholesterol homeostasis in man. Response to changes in dietary fat quality and cholesterol quantity. J Clin Invest 1987; 79: 17291739
  • 23
    Kern F Jr: Normal plasma cholesterol in an 88-year-old man who eats 25 eggs a day. N Engl J Med 1991; 324: 896899
  • 24
    Sehayek E, Nath C, Heinemann T, McGee M, Seidman CE, Samuel P, Breslow JL: Ushape relationship between change in dietary cholesterol absorption and plasma lipoprotein responsiveness and evidence for extreme interindividual variation in dietary cholesterol absorption in humans. J Lipid Res 1998; 39: 24152422
  • 25
    Bosner MS, Lange LG, Stenson WF, Ostlund RE Jr: Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry. J Lipid Res 1999; 40: 302308
  • 26
    Mittendorfer B, Ostlund RE Jr, Patterson BW, Klein S: Orlistat inhibits dietary cholesterol absorption. Obes Res 2001; 9: 599604
  • 27
    Rajaratnam RA, Gylling H, Miettinen TA: Cholesterol absorption, synthesis, and fecal output in postmenopausal women with and without coronary artery disease. Arterioscler Thromb Vasc Biol 2001; 21: 16501655
  • 28
    Beynen AC, Katan MB, Van Zutphen LFM: Hypo- and hyperresponders: Individual differences in the response of serum cholesterol concentration to changes in diet. In Advances in Lipid Research (Eds. Paoletti R, Kritchevsky D), p. 115171. New York: Academic Press, Inc., 1987
  • 29
    Schwarz M, Davis DL, Vick BR, Russell DW: Genetic analysis of intestinal cholesterol absorption in inbred mice. J Lipid Res 2001; 42:1801-1811
  • 30
    Sehayek E: Genetic regulation of cholesterol absorption and plasma plant sterol levels: Commonalities and differences. J Lipid Res 2003; 44: 20302038
  • 31
    Miettinen TA, Gylling H, Strandberg T, Sarna S: Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian Simvastatin Survival Study. Finnish 4S Investigators. Br Med J 1998; 316: 11271130
  • 32
    Grundy SM, Ahrens EH, Salen G: Interruption of the enterohepatic circulation of bile acids in man: Comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism. J Lab Clin Med 1971; 78: 94121
  • 33
    Davidson MH, Dillon MA, Gordon B, Jones PJ, Samuels J, Weiss S, Isaacsohn J, Toth P, Burke SK: Colesevelam hydrocholoride (Cholestagel). A new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects. Arch Intern Med 1999; 159: 18931900
  • 34
    Black DM: Gut-acting drugs for lowering cholesterol. Curr Atheroscler Reports 2002; 4: 7175
  • 35
    Katan MB, Grundy SM, Jones P, Law M, Miettinen T, Paoletti R: Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 2003; 78: 965978
  • 36
    Crouse JR, Grundy SM: Effects of sucrose polyester on cholesterol metabolism in man. Metabolism 1979; 28: 9941000
  • 37
    Kesäniemi YA, Grundy SM: Turnover of low density lipoproteins during inhibition of cholesterol absorption by neomycin. Arteriosclerosis 1984; 4: 4148
  • 38
    Knopp RH, Dujovne CA, LeBeaut A, Lipka LJ, Suresh R, Veltri EP: Evaluation of the efficacy, safety, and tolerability of ezetimibe in primary hypercholesterolaemia: A pooled analysis from two controlled phase III clinical studies. Int J Clin Pract 2003; 57: 363368
  • 39
    Gagné C, Gaudet D, Bruckert E: Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia. Circulation 2002; 105: 24692475
  • 40
    Gagné C, Bays HE, Weiss SR, Mata P, Quinto K, Melino M, Cho M, Musliner TA, Gumbiner B: Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia. Am J Cardiol 2002; 90: 10841091
  • 41
    Salen G, von Bergmann K, Lütjohann D, Kwiterovich P, Kane J, Patel SB, Musliner T, Stein P, Musser B: Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia. Circulation 2004; 109: 966971
  • 42
    Bruckert E: New advances in lipid-modifying therapies for reducing cardiovascular risk. Cardiology 2002; 97: 5966
  • 43
    Sudhop T, von Bergmann K: Cholesterol absorption inhibitors for the treatment of hypercholesterolaemia. Drugs 2002; 62: 23332347
  • 44
    Ginsberg HN: Treatment for patients with the metabolic syndrome. Am J Cardiol 2003; 91: 29E-39E
  • 45
    Turley SD, Spady DK, Dietschy JM: Identification of a metabolic difference accounting for the hyper- and hyporesponder phenotypes of cynomolgus monkey. J Lipid Res 1997; 38: 15981611
  • 46
    Davidson MH, McGarry T, Bettis R, Melani L, Lipka LJ, LeBeaut AP, Suresh R, Sun S, Veltri EP: Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia. J Am Coll Cardiol 2002; 40: 21252134
  • 47
    Ballantyne CM, Houri J, Notarbartolo A, Melani L, Lipka LJ, Suresh R, Sun S, LeBeaut AP, Sager PT, Veltri EP: Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: A prospective, randomized, double-blind trial. Circulation 2003; 107: 24092415